Open AccessPolycystic ovary syndrome in patients on antiepileptic drugs
Author(s) -
Lakshminarayanapuram Gopal Viswanathan,
Parthasarathy Satishchandra,
Bipin C. Bhimani,
Janardhan Y. C. Reddy,
Batchu S Rama Murthy,
D. K. Subbakrishna,
Sanjib Sinha
Publication year - 2016
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.179973
Subject(s) - carbamazepine , polycystic ovary , medicine , epilepsy , population , pediatrics , gynecology , obesity , psychiatry , insulin resistance , environmental health
This study aims to discuss the prevalence of polycystic ovary (PCO) and Polycystic ovary syndrome (PCOS) in women with epilepsy (WWE) on valproate (VPA), carbamazepine (CBZ), or phenobarbitone (PB), drug naive WWE and women with bipolar affective disorder (BPAD) on VPA.